T2 Biosystems Q2 2024 GAAP EPS $(0.66) Beats $(0.97) Estimate, Sales $1.952M Miss $2.100M Estimate
Author: Benzinga Newsdesk | July 29, 2024 04:22pm
T2 Biosystems (NASDAQ:
TTOO) reported quarterly losses of $(0.66) per share which beat the analyst consensus estimate of $(0.97) by 31.96 percent. The company reported quarterly sales of $1.952 million which missed the analyst consensus estimate of $2.100 million by 7.05 percent. This is a 0.61 percent decrease over sales of $1.964 million the same period last year.
Posted In: TTOO